[Federal Register Volume 62, Number 45 (Friday, March 7, 1997)] [Notices] [Pages 10575-10576] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-5559] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Health Resources and Services Administration (HRSA) publishes abstracts of information collection requests under review by the Office of Management and Budget, in compliance with the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). To request a copy of the clearance requests submitted to OMB for review, call the HRSA Reports Clearance Office on (301)-443-1129. The following request has been submitted to the Office of Management and Budget for review under the Paperwork Reduction Act of 1995: Customer Survey of Entities Eligible To Participate in the Drug Pricing Program--New Section 602 of the Veterans Health Care Act of 1992 enacted Section 340B of the Public Health Service (PHS) Act, ``Limitation of Prices of Drugs Purchased by Covered Entities.'' This section provides that a manufacturer that sells outpatient drugs to covered [[Page 10576]] entities must agree to charge a price that will not exceed the amount determined under a statutory formula. The covered entities--certain PHS grantees, disproportionate share hospitals (DSHs), and other selected entities, total approximately 11,000 sites. Most of these entities serve the economically disadvantaged or medically uninsured. The legislative intent of Section 340B is ``to enable * * * certain Federally-funded clinics to obtain lower prices on the drugs that they provide to their patients.'' Because of the significant savings that covered entities can realize if they are able to access Section 602 pricing, it is imperative to know the degree of satisfaction with various aspects of the program service and where improvements can be made; and to identify the barriers to access and what changes can be made to reduce them. The HRSA Office of Drug Pricing Program (ODPP)administers the program and has designed a survey with questions that relate to the two areas that they can modify readily: The availability of information about the program, and the design of the program. The survey also includes questions on the amount of savings realized by participating entities, how the savings are used, and factors affecting satisfaction with savings. Participating and non-participating entities will be surveyed, and the results will be used to guide program changes that will increase customer satisfaction and ultimately increase program participation. The estimated burden is as follows: ---------------------------------------------------------------------------------------------------------------- Burden per Respondents Number of Responses per response Total burden Respondents respondent (hours) hours ---------------------------------------------------------------------------------------------------------------- Covered entities............................ 1,508 1 .25 377 ---------------------------------------------------------------------------------------------------------------- Written comments and recommendations concerning the proposed information collection should be sent within 30 days of this notice to: Laura Oliven, Human Resources and Housing Branch, Office of Management and Budget, New Executive Office Building, Room 10235, Washington, D.C. 20503. Dated: March 3, 1997. J. Henry Montes, Director, Office of Policy and Information Coordination. [FR Doc. 97-5559 Filed 3-6-97; 8:45 am] BILLING CODE 4160-15-P